Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Accessory Structures of the Eye01:17

Accessory Structures of the Eye

Optical perception, or vision, is an extraordinary sense dependent on converting light signals received via the ocular organs. These organs, known as eyes, are securely positioned within the bony cavities of the skull, called orbits. The orbits serve a dual purpose: a protective shield for the ocular globes and a stable attachment point for the soft ocular tissues. The eye's external protective mechanisms include the eyelids, which are edged with lashes that act as a barrier against foreign...
Direct-Acting Cholinergic Agonists: Therapeutic Uses01:11

Direct-Acting Cholinergic Agonists: Therapeutic Uses

Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.
Cholinergic Antagonists: Therapeutic Uses01:26

Cholinergic Antagonists: Therapeutic Uses

Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:    
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A general model for the motion of multivalent cargo interacting with substrates.

Journal of the Royal Society, Interface·2023
Same author

Migraine patients in Germany - need for medical recognition and new preventive treatments: results from the PANORAMA survey.

The journal of headache and pain·2021
Same author

[Trigeminal neuralgia: treatment options for refractory cases].

MMW Fortschritte der Medizin·2019
Same author

[Headache again].

MMW Fortschritte der Medizin·2018
Same author

[Treatment of chronic migraine with botulinum neurotoxin A : Expert recommendations of the German Migraine and Headache Society].

Der Nervenarzt·2018
Same author

[Modern non-cosmetic treatment with botulinum toxins].

Der Internist·2017

Related Experiment Video

Updated: Jul 16, 2026

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

Therapeutic considerations for eye movement disorders.

A Straube1

  • 1Department of Neurology, University of Munich, Munich, Germany. andreas.straube@med.uni-muenchen.de

Developments in Ophthalmology
|February 23, 2007
PubMed
Summary

This chapter reviews pharmacological treatments for eye movement disorders. Therapies include cortisone for vestibular neuritis and 4-aminopyridine for nystagmus, improving patient outcomes.

Area of Science:

  • Neuroscience
  • Ophthalmology
  • Pharmacology

Background:

  • Understanding the pathophysiology of eye movement disorders has advanced significantly.
  • Translating these advances into effective treatment strategies is a recent development.

Purpose of the Study:

  • To summarize current pharmacological treatment options for various oculomotor syndromes.
  • To highlight recent therapeutic advancements in managing eye movement disorders.

Main Methods:

  • Review of established and emerging pharmacological and therapeutic interventions.
  • Discussion of treatments based on the underlying pathophysiology of specific disorders.

Main Results:

  • Cortisone is effective for acute vestibular neuritis, aiding labyrinthine function recovery.

More Related Videos

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis
07:00

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis

Published on: October 13, 2016

VisualEyes: A Modular Software System for Oculomotor Experimentation
10:41

VisualEyes: A Modular Software System for Oculomotor Experimentation

Published on: March 25, 2011

Related Experiment Videos

Last Updated: Jul 16, 2026

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis
07:00

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis

Published on: October 13, 2016

VisualEyes: A Modular Software System for Oculomotor Experimentation
10:41

VisualEyes: A Modular Software System for Oculomotor Experimentation

Published on: March 25, 2011

  • Canalith repositioning maneuvers are established for benign paroxysmal positioning nystagmus.
  • 4-aminopyridine treats central vestibular nystagmus by modulating cerebellar circuits.
  • Memantine shows efficacy for acquired pendular nystagmus, often associated with multiple sclerosis.
  • Anticonvulsants like carbamazepine are indicated for vestibular paroxysmia and superior oblique myokymia.

    • Conclusions:

    • Pharmacological and therapeutic interventions offer diverse strategies for managing oculomotor syndromes.
    • Targeted treatments based on pathophysiology are improving outcomes for patients with eye movement disorders.